The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
Abstract
The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA methyltransferases, DNA methyltransferase (Dnmt)3a and Dnmt3b (Dnmt3s). Glutathione-S-transferase pulldown assay revealed that PU.1 directly interacted with the ATRX domain of Dnmt3s through the ETS domain. Dnmt3s repressed the transcriptional activity of PU.1 on a reporter construct with trimerized PU.1-binding sites. The repression was recovered by addition of 5-aza-deoxycitidine, a DNA methyltransferase inhibitor, but not trichostatin A, a histone deacetylase inhibitor. Bisulfite sequence analysis revealed that several CpG sites in the promoter region neighboring the PU.1-binding sites were methylated when Dnmt3s were coexpressed with PU.1. We also showed that the CpG sites in the p16(INK4A) promoter were methylated by overexpression of PU.1 in NIH3T3 cells, accompanied by a downregulation of p16(INK4A) gene expression. These results suggest that PU.1 may downregulate its target genes through an epigenetic modification such as DNA methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that PU.1 can form a complex with DNMT3a and DNMT3b [46].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [46]
Citations
Cites
1 retracted
Majumder, S., Ghoshal, K., Datta, J., Bai, S., Dong, X. C., Quan, N., Plass, C., & Jacob, S. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111662200 · Cited by 54 · cited 1×
“There is growing evidence to suggest that Dnmt1 interacts with the methylated DNAbinding protein (MBD) family (Tatematsu et al., 2000) and that Dnmt3s mediate the binding of MBD family members such as MeCP2 to methylated CpG sites (Majumder et al., 2002).”
BackgroundRetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“Histone deacetylase removes the acetyl groups from the amino-terminal of the histone tails, which triggers the assembly of a tightly packed chromatin inaccessible to the transcriptional machinery (Jenuwein and Allis, 2001).”
BackgroundMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646 · cited 1×
“The method of bisulfite treatment has been explained previously (Herman et al., 1996).”
MethodMethylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651 · cited 2×
“Recent observations convinced us that the two major epigenetic gene-silencing mechanisms, the acetylation of histones and the methylation of DNA, are linked to Oncogene each other (Okano et al., 1998).”
BackgroundDNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052 · cited 1×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · cited 1×
“PU.1 was identified as the gene encoding the protein that binds to a purine-rich sequence (PU box) in the promoter region of the mouse major histocompatibility complex (MHC) class II I-Ab gene (Klemsz et al., 1990).”
BackgroundRobertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942 · cited 2×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundCloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells
Bestor, T., Laudano, A., Mattaliano, R., & Ingram, V. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90122-2 · Cited by 913 · cited 1×
“There are at least three different major catalytically active Dnmts, Dnmt1 (Bestor et al., 1988), Dnmt3a and Dnmt3b (Okano et al., 1998), which are involved in cellular DNA methylation.”
BackgroundDi Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787 · cited 1×
“The report that a complex of the PML–RAR fusion protein and Dnmts contributes to hypermethylation of the RARb2 promoter to silence the gene expression is the first example of site-specific DNA methylation (Croce et al., 2002).”
BackgroundDNA methylation, methyltransferases, and cancer
Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 736 · cited 2×
“Among the three DNA methyltransferases (Dnmts) isolated to date, Dnmt1 and Dnmt3a/Dnmt3b, the former has been shown to function as a maintenance methylase and the latter two as de novoDNA methylases (Robertson 2001).”
BackgroundTranscription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 2×
“…a transcription factor that belongs to the Ets family and controls the expression of many Bcell- and macrophage-specific genes, including the immunoglobulin genes and the macrophage colony stimulation factor receptor (M-CSFR) gene (MoreauGachelin, 1994; Tenen et al., 1997; Oikawa et al., 1999).”
BackgroundSelf-citationRegulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733 · cited 1×
“The various deletion mutants of p16 promoter-Luc vector constructs have been described previously (Hara et al., 1996). pCMV-FLAG-Dnmt3a and pCMV- FLAG-Dnmt3b were constructed as described above.”
MethodSelf-citationMolecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 1×
“PU.1 was originally characterized as a transcriptional activator during hematopoietic differentiation (Tenen et al., 1997; Oikawa and Yamada, 2003).”
BackgroundSelf-citationOpposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
Ohtani, N., Zebedee, Z., Huot, T. J. G., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., & Hara, E. (2001) · Nature · doi:10.1038/35059131 · Cited by 654 · cited 1×
“The promoter region of the p16 gene, a cyclin-dependent kinase inhibitor gene, has several Etsbinding sites (Ohtani et al., 2001) and many CpG sites (Figure 7a).”
BackgroundSelf-citationDNA methylation and chromatin modification
Ng, H.-H., & Adrian, B. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80024-0 · Cited by 648
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 1×
“Overexpression and graded reduction of PU.1 induce erythroleukemia and myeloid leukemia in mice, respectively (Moreau-Gachelin et al., 1996; Rosenbauer et al., 2004).”
BackgroundSelf-citationDnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription
Fuks, F., Burgers, W. A., Godin, N., Kasai, M., & Kouzarides, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2536 · Cited by 473 · cited 2×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundDNA methylation and chromatin – unraveling the tangled web
Robertson, K. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205609 · Cited by 471 · cited 1×
“It is documented that the methylation of CpG islands is associated with changes in chromatin structure and the repression of gene transcription (Robertson, 2002).”
BackgroundPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · cited 2×
“PU.1 functions in concert with other transcription factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ A…”
Bachman, K. E., Rountree, M. R., & Baylin, S. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104661200 · Cited by 438 · cited 1×
“Epigenetic transcriptional repression of PU.1-mediated reporter activity by Dnmt3s Several studies have shown that Dnmt3a and Dnmt3b are associated with HDAC1 and HDAC2 in vivo and in vitro (Robertson et al., 2000; Bachman et al., 2001; Fuks et al., 2001).”
BackgroundZhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411 · cited 2×
“PU.1 functions in concert with other transcription factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ A…”
Self-citationCytosine methylation and mammalian development
Walsh, C. P., & Bestor, T. H. (1999) · Genes & Development · doi:10.1101/gad.13.1.26 · Cited by 388 · cited 1×
“In this connection, it has been reported that knockout mice deficient in Dnmt1 are prone to developing malignant tumors (Walsh and Bestor, 1999).”
BackgroundVangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., & Behre, G. (2003) · Blood · doi:10.1182/blood-2002-04-1288 · Cited by 245 · cited 1×
“Furthermore, an aberrant expression of PU.1 is associated with the development of myeloid leukemia in humans (Muller et al., 2002; Vangala et al., 2003).”
BackgroundSelf-citationHeterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Self-citationC/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter
Oelgeschläger, M., Nuchprayoon, I., Lüscher, B., & Friedman, A. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4717 · Cited by 229 · cited 2×
“PU.1 functions in concert with other transcription factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ A…”
BackgroundSpi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189 · cited 1×
“Overexpression and graded reduction of PU.1 induce erythroleukemia and myeloid leukemia in mice, respectively (Moreau-Gachelin et al., 1996; Rosenbauer et al., 2004).”
BackgroundA direct physical association between ETS and AP-1 transcription factors in normal human T cells
Bassuk, A. G., & Leiden, J. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90092-6 · Cited by 186 · cited 1×
“…factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ AML1 (Zhang et al., 1994).”
Tatematsu, K., Yamazaki, T., & Ishikawa, F. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00359.x · Cited by 173 · cited 1×
“There is growing evidence to suggest that Dnmt1 interacts with the methylated DNAbinding protein (MBD) family (Tatematsu et al., 2000) and that Dnmt3s mediate the binding of MBD family members such as MeCP2 to methylated CpG sites (Majumder et al., 2002).”
BackgroundSingal, R., & Ginder, G. D. (1999) · Blood · doi:10.1182/blood.v93.12.4059.412k40_4059_4070 · Cited by 152
Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP
Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y., & Oikawa, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202427 · Cited by 113 · cited 8×
“Immunoprecipitation and immunoblotting were performed as we reported (Yamamoto et al., 1999), with minor modifications.”
BackgroundMethodInfluentialSelf-citationNagulapalli, S., Pongubala, J. M., & Atchison, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4330 · Cited by 110
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110
Oikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109 · cited 1×
“…a transcription factor that belongs to the Ets family and controls the expression of many Bcell- and macrophage-specific genes, including the immunoglobulin genes and the macrophage colony stimulation factor receptor (M-CSFR) gene (MoreauGachelin, 1994; Tenen et al., 1997; Oikawa et al., 1999).”
BackgroundSelf-citationRao, G., Rekhtman, N., Cheng, G., Krasikov, T., & Skoultchi, A. I. (1997) · Oncogene · doi:10.1038/sj.onc.1200807 · Cited by 89 · cited 1×
“Furthermore, sustained expression of PU.1 in erythroblasts is believed to contribute to the blocking of erythroid differentiation, as we and others have reported (Rao et al., 1997; Yamada et al., 1997).”
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 87 · cited 8×
“Coexistence with Dnmt3s and HDAC1-mSin3A–PU.1 complex We previously reported that MeCP2 preferentially recruits the Sin3A–HDAC complex to PU.1 (Suzuki et al., 2003).”
BackgroundMethodInfluentialSelf-citationYamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., & Oikawa, T. (1997) · Blood · doi:10.1182/blood.v89.4.1383 · Cited by 87 · cited 1×
“Furthermore, sustained expression of PU.1 in erythroblasts is believed to contribute to the blocking of erythroid differentiation, as we and others have reported (Rao et al., 1997; Yamada et al., 1997).”
Self-citationPU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86 · cited 1×
“…factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ AML1 (Zhang et al., 1994).”
Datta, J., Ghoshal, K., Sharma, S. M., Tajima, S., & Jacob, S. T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10457 · Cited by 75 · cited 1×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundKihara-Negishi, F., Yamamoto, H., Suzuki, M., Yamada, T., Sakurai, T., Tamura, T., & Oikawa, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204756 · Cited by 69 · cited 1×
“We have also demonstrated that PU.1 binds to the corepressor mSin3A and forms a complex with histone deacetyl transferase (HDAC)1 (Kihara-Negishi et al., 2001).”
BackgroundSelf-citationLinderson, Y., Eberhard, D., Malin, S., Johansson, A., Busslinger, M., & Pettersson, S. (2004) · The EMBO Reports · doi:10.1038/sj.embor.7400089 · Cited by 64 · cited 1×
“…status of the promoter region of pTK100PUx3-Luc is PU.1- and Dnmt3-dependent. p16 gene, a putative target gene controlled by PU.1 There are very few reports indicating that the repression of cell-type-specific gene expression is mediated by PU.1 (Hwang et al., 2004; Linderson et al., 2004).”
BackgroundTranscriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 52
GOOSECOID inhibits erythrocyte differentiation by competing with Rb for PU.1 binding in murine cells
Konishi, Y., Tominaga, M., Watanabe, Y., Imamura, F., Goldfarb, A. N., Maki, R. A., Blum, M., Robertis, E. M. D., & Tominaga, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203118 · Cited by 21 · cited 1×
“…factors and cofactors, including c-Myb, C/EBPa (Oelgeschlager et al., 1996), NF-IL-6 (C/EBPd) (Nagulapalli et al., 1995), NF-EM-5/Pip (Eisenbeis et al., 1995), cFos (Bassuk and Leiden, 1995), c-Jun (Pongubala and Atchison, 1997), Rb (Konishi et al., 1999) and RUNX1/ AML1 (Zhang et al., 1994).”
Research works printed but not linked: 1
- Zhang DE, Hetherington CJ, Chen HM, Tenen DG . (1994). Mol Cell Biol 14: 373–381. · doi:10.1128/mcb.14.1.373 · Paper page
Cited by
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
“DNMT3a and DNMT3b are responsible for de novo DNA methylation, targeting unmethylated CpG dinucleotides (Newell-Price et al., 2000; Wang et al., 2005; Suzuki et al., 2006; Hervouet et al., 2009), as well as working with DNMT1 to ensure propagation of methylation patterns during DNA replication (Weber and Schübeler, 20…”
BackgroundStructure and Function of Mammalian DNA Methyltransferases
Jurkowska, R. Z., Jurkowski, T. P., & Jeltsch, A. (2011) · ChemBioChem · doi:10.1002/cbic.201000195 · Cited by 690
Genomic patterns of DNA methylation: targets and function of an epigenetic mark
Weber, M., & Schübeler, D. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.011 · Cited by 387
Identification of genetic elements that autonomously determine DNA methylation states
Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F., & Schübeler, D. (2011) · Nature Genetics · doi:10.1038/ng.946 · Cited by 386
Sensitivity of transcription factors to DNA methylation
Héberlé, É., & Bardet, A. F. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190033 · Cited by 347
Metadata
- Authors
- Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T.
- Affiliations
- Sasaki Institute (JP)
- Tokushima University (JP)
- Harvard University (US)
- Tokyo University of Science (JP)
- Corresponding author
- Oikawa, T
- Venue
- Oncogene
- Published
- 2005-12-05
- Volume
- 25
- Issue
- 17
- Pages
- 2477-2488
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1984410404
- Cited by
- 132
- References
- 43
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 10 · 2021: 6 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 2 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 4
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- PU.1, DNMT3A, DNMT3B, DNA methylation, transcriptional repression, ETS transcription factors, CpG methylation, p16INK4a, epigenetic regulation, hematopoietic transcription factors, decitabine
- MeSH terms
- Decitabine, DNA Methyltransferase 3A, DNA Methyltransferase 3B, Proto-Oncogene Protein Spi-1, Animals, Azacitidine, DNA (Cytosine-5-)-Methyltransferases, Histone Deacetylases, Hydroxamic Acids, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p16, NIH 3T3 Cells, Chromatin Immunoprecipitation, Immunoprecipitation, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.